Sanofi Looks to Second-Generation Emerging Markets with Genfar Acquisition

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 10 (Table of Contents)

Published: 24 Oct-2012

DOI: 10.3833/pdr.v2012.i10.1823     ISSN: 1756-7874

Section: Mergers & Acquisitions



Only weeks after declaring that it was seeking deal opportunities in second-generation emerging markets such as Vietnam, Indonesia and Colombia, Sanofi has agreed to acquire Genfar, the second-largest generics company in Colombia in terms of sales...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details